Home Based Intervention Led by Nurse in Brazil
HFHELENI
Home Visit Impact on Knowledge of Disease, Self-Care Skills and Quality of Life of Heart Failure Patients: Randomized Clinical Trial
1 other identifier
interventional
200
0 countries
N/A
Brief Summary
Home visits (HV) are one of the multidisciplinary approaches that has already shown to benefit the follow-up of Heart Failure (HF) patients. It is considered to be one of the most effective and humane approaches as it educates and takes care of the patient in his/her routine environment. In this study, the follow-up of HF patients in a home setting after being discharged from hospital will include the reinforcement, monitoring and re-evaluation of guidelines previously provided about the disease and self-care, compliance to prescribed medicines and, specially, the early recognition of decompensation signs and symptoms by patients and their caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Aug 2009
Typical duration for not_applicable heart-failure
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 9, 2009
CompletedFirst Posted
Study publicly available on registry
October 4, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedJanuary 3, 2014
December 1, 2013
3.4 years
November 9, 2009
December 31, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Knowledge of the disease
This primary outcome will be measured at each home visit, which will have different intervals, according to the research protocol.
Home visit 7 days after discharge
Self-care skills.
This primary outcome will be measured at each home visit, which will have different intervals, according to the research protocol.
Home visit 7 days after discharge.
Quality of Life
This primary outcome will be measured at each home visit, which will have different intervals, according to the research protocol.
Home visit 7 days after discharge
Secondary Outcomes (3)
Changes in functional class.
Home visits (HV) starting 7days after discharge.
Presentation to emergency department
Home visits starting 7 days after discharge.
Compliance score.
Home visits starting 7 days after discharge.
Study Arms (1)
intervention and control
EXPERIMENTAL* Group I - Intervention: Routine follow-up in a reference health institution with four home visits and four telephone contacts with specialist nurses. * Group II - Control: Routine follow-up with the health team in the reference institution.
Interventions
There will provided education about what is heart failure, its causes, how to recognize signs and symptoms, monitoring of weight and blood pressure, the importance of compliance to treatment. Patients will be instructed about the medications; a guide to rest and exercise, sexual activity, vaccines, travel and diet will be provided. The involvement of the family will be encouraged; the contact with the team should be done when: patient observes an increase of 1 or 2 kg of weight in 2-3 days, worsening of dyspnea on effort, edema in legs / abdomen, worsening of cough, persistent vomiting, syncope, sputum with blood, fever, persistent tachycardia. In phone calls made between home visits, the compliance to treatment will be evaluated and reinforced.
Eligibility Criteria
You may qualify if:
- Patients of both sexes
- Age equal to or above 18 years
- Diagnosis of heart failure with systolic dysfunction (ejection fraction ≤ 45%)
- Hospitalized for heart failure decompensation and who agree to participate in the study by signing a Free Informed Consent Form.
You may not qualify if:
- Patients presenting with communication barriers and suffering from degenerative neurological diseases.
- Patients who had Acute Coronary Syndrome (ACS) in the past 6 months before randomization
- Patients with renal/hepatic/pulmonary or systemic disease who may confuse the interpretation of findings or result in limited life expectancy
- Surgical or therapeutic treatment that may influence the follow-up
- Pregnancy
- Diagnosis of Heart Failure secondary to:
- sepsis
- myocarditis
- acute myocardial infarction
- peripartum cardiomyopathy and other acute cause
- No interest in receiving home visits
- Living more than 10 km away for the original hospital
- No possibility of telephone contact.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Mussi CM, Ruschel K, de Souza EN, Lopes AN, Trojahn MM, Paraboni CC, Rabelo ER. Home visit improves knowledge, self-care and adhesion in heart failure: Randomized Clinical Trial HELEN-I. Rev Lat Am Enfermagem. 2013 Jan-Feb;21 Spec No:20-8. doi: 10.1590/s0104-11692013000700004. English, Portuguese.
PMID: 23459887DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eneida R Rabelo da Silva, RN, ScD
Federal University of Rio Grande do Sul
- PRINCIPAL INVESTIGATOR
Eneida R Rabelo da Silva, RN, ScD
Universidade Federal do Rio do Sul
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, PhD.
Study Record Dates
First Submitted
November 9, 2009
First Posted
October 4, 2010
Study Start
August 1, 2009
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
January 3, 2014
Record last verified: 2013-12